Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry

Tissue-Sparing Application of the Newly Proposed IASLC/ATS/ERS Classification of Adenocarcinoma of the Lung Shows Practical Diagnostic and Prognostic Impact

(2012) William Sterlacci et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system

(2012) Jason C Carvalho et al.   HISTOPATHOLOGY

p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers

(2012) Woonyoung Choi et al.   PLoS One

p63 Immunohistochemical Staining Is Limited in Soft Tissue Tumors

(2011) Vickie Y. Jo et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer Progression

(2011) Orit Karni-Schmidt et al.   AMERICAN JOURNAL OF PATHOLOGY

Toll-like Receptor 3 (TLR3) Induces Apoptosis via Death Receptors and Mitochondria by Up-regulating the Transactivating p63 Isoform α (TAP63α)

(2011) Ruili Sun et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression of p63 is the sole independent marker of aggressiveness in localised (stage I–II) Merkel cell carcinomas

(2011) Sofia Asioli et al.   MODERN PATHOLOGY

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens

(2011) Natasha Rekhtman et al.   MODERN PATHOLOGY

p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma

(2011) Justin A Bishop et al.   MODERN PATHOLOGY

Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens

(2010) Sanjay Mukhopadhyay et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

p63in Epithelial Survival, Germ Cell Surveillance, and Neoplasia

(2010) Christopher P. Crum et al.   Annual Review of Pathology-Mechanisms of Disease

Evaluation of p63 and p73 antibodies for cross-reactivity

(2010) Jennifer M. Rosenbluth et al.   CELL CYCLE

Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy

(2010) Yeon-Joo Kim et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs

(2010) Xiaohua Su et al.   NATURE

Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma

(2010) Maximilian Moergel et al.   ORAL ONCOLOGY

Clinical relevance of the putative stem cell marker p63 in breast cancer

(2009) L. Hanker et al.   BREAST CANCER RESEARCH AND TREATMENT

Loss of  Np63  Promotes Invasion of Urothelial Carcinomas via N-Cadherin/Src Homology and Collagen/Extracellular Signal-Regulated Kinase Pathway

(2009) H. Fukushima et al.   CANCER RESEARCH

TAp63 induces senescence and suppresses tumorigenesis in vivo

(2009) Xuecui Guo et al.   NATURE CELL BIOLOGY

Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death

(2009) Stefania Gonfloni et al.   NATURE MEDICINE

The Origins and Evolution of the p53 Family of Genes

(2009) V. A. Belyi et al.   Cold Spring Harbor Perspectives in Biology